Authors/Disclosures
|
|
No disclosure on file |
|
Shiney Koshy, MD
(Kaiser Permanente)
|
No disclosure on file |
|
|
No disclosure on file |
|
Heather Mattick
|
No disclosure on file |
|
Danielle M. Andrade, MD
(University of Toronto)
|
The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
Carol Moore
(Henry Jackson Foundation/USUHS)
|
No disclosure on file |
|
Caryn Harper
|
No disclosure on file |
|
Jun Shimizu, MD, PhD
(Tokyo University of Technology)
|
No disclosure on file |
|
|
No disclosure on file |
|
Ramon R. Diaz-Arrastia, MD, PhD, FÂ鶹´«Ã½Ó³»
(University of Pennsylvania)
|
Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |